Our company operates in the booming industry of Precision Medicine and Genetic Analysis. Our focus is on developing and providing genetic analysis for Pharmacogenetics. Preventive Medicine and Genomics of Nutrition and Sports, with constant research activity through co-operation with universities in Greece and abroad.
We specialise in Genetics and fully exploit cutting-edge scientific knowledge, to provide innovative DNA analysis services that allow everybody to access their unique genetic traits, with a personalised approach.
We develop innovative and pioneering solutions by leveraging our multidimensional expertise, our scientific staff and Research & Development (R&D) department, the certified laboratories and privately owned bioinformatics analysis platform, a state-of-the-art technology and the collaboration with prestigious Universities and Research Organisations.
2020
Served areaCyprus
Headquarters6 Theotokis Street, 3rd Floor, 1055 Nicosia – Cyprus
2,600,000
IPODec. 17, 2021
Stock exchange(s)Cyprus Stock Exchange